Clinical Research Directory
Browse clinical research sites, groups, and studies.
Stavanger University Hospital Inflammatory Bowel Disease Trial
Sponsor: Helse Stavanger HF
Summary
The study aims at studying the outcomes of a protocol-based handling of newly diagnosed Inflammatory bowel disease ( IBD ) patients within a defined uptake area in Norway. It is a descriptive study and no hypothesis is predefined. Cytokine studies, QoL and fatigue assessment will be included for hypothesis-generating purposes.
Official title: Management of Inflammatory Bowel Disease in the Stavanger Area - a Prospective Evaluation of Standardized Treatment Regimens on Disease Outcome With Focus on Mucosal Healing and Associations to Fatigue
Key Details
Gender
All
Age Range
16 Years - 80 Years
Study Type
OBSERVATIONAL
Enrollment
700
Start Date
2012-04
Completion Date
2030-12
Last Updated
2025-05-16
Healthy Volunteers
No
Conditions
Locations (1)
SUS
Stavanger, Norway